Axa’s Synaptics SYNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-25,800
Closed -$5.15M 1207
2022
Q1
$5.15M Buy
+25,800
New +$5.72M 0.01% 638
2021
Q3
Sell
-43,900
Closed -$6.83M 1318
2021
Q2
$6.83M Sell
43,900
-22,100
-33% -$2.99M 0.02% 628
2021
Q1
$8.94M Sell
66,000
-10,700
-14% -$1.3M 0.03% 545
2020
Q4
$7.39M Hold
76,700
0.02% 598
2020
Q3
$6.17M Hold
76,700
0.02% 568
2020
Q2
$4.61M Buy
76,700
+21,100
+38% +$1.32M 0.02% 639
2020
Q1
$3.22M Sell
55,600
-44,100
-44% -$2.99M 0.02% 635
2019
Q4
$6.56M Sell
99,700
-10,300
-9% -$543K 0.03% 552
2019
Q3
$4.39M Sell
110,000
-4,300
-4% -$145K 0.02% 691
2019
Q2
$3.33M Sell
114,300
-24,800
-18% -$809K 0.01% 757
2019
Q1
$5.53M Buy
139,100
+1,500
+1% +$59.3K 0.02% 619
2018
Q4
$5.12M Buy
137,600
+51,000
+59% +$1.92M 0.02% 596
2018
Q3
$3.95M Buy
86,600
+39,700
+85% +$1.89M 0.01% 729
2018
Q2
$2.36M Buy
46,900
+27,600
+143% +$1.25M 0.01% 817
2018
Q1
$883K Buy
19,300
+800
+4% +$36.3K ﹤0.01% 1034
2017
Q4
$739K Buy
18,500
+300
+2% +$11.5K ﹤0.01% 1079
2017
Q3
$713K Buy
+18,200
New +$821K ﹤0.01% 1039
2016
Q1
Sell
-10,200
Closed -$819K 1409
2015
Q4
$819K Buy
+10,200
New +$866K ﹤0.01% 951
2015
Q3
Sell
-42,000
Closed -$3.64M 1513
2015
Q2
$3.64M Buy
42,000
+1,000
+2% +$91.3K 0.01% 655
2015
Q1
$3.33M Buy
41,000
+3,400
+9% +$257K 0.01% 688
2014
Q4
$2.59M Buy
37,600
+6,600
+21% +$442K 0.01% 724
2014
Q3
$2.27M Buy
+31,000
New +$2.53M 0.01% 715
2014
Q1
Sell
-45,300
Closed -$2.35M 1460
2013
Q4
$2.35M Buy
45,300
+7,500
+20% +$368K 0.01% 730
2013
Q3
$1.67M Buy
37,800
+1,600
+4% +$65.5K 0.01% 780
2013
Q2
$1.4M Buy
+36,200
New +$1.45M 0.01% 776

Other funds holding SYNA

Axa's SYNA Position: Q2 2022 in Review

Axa sold out of Synaptics (SYNA) in Q2 2022, closing a stake of 25,800 shares — an estimated $5.15M sold.

Axa first reported a position in SYNA in Q2 2013 and held it in 25 quarters. The position peaked at $8.94M in Q1 2021. 319 funds tracked by Wall St. Rank hold SYNA as of Q2 2022.

  • Axa reported no remaining Synaptics position as of Q2 2022 after selling out during the quarter.
  • Axa sold 25,800 Synaptics shares in Q2 2022, an estimated $5.15M.
  • Axa first reported a position in Synaptics in Q2 2013 and held it in 25 quarters.
  • Axa's Synaptics position peaked at $8.94M in Q1 2021.
  • 319 funds tracked by Wall St. Rank held Synaptics as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.